Leerink Partnrs Forecasts McKesson’s Q4 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK) – Equities research analysts at Leerink Partnrs lifted their Q4 2025 earnings estimates for shares of McKesson in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $9.96 for the quarter, up from their prior estimate of $9.86. The consensus estimate for McKesson’s current full-year earnings is $32.72 per share. Leerink Partnrs also issued estimates for McKesson’s FY2026 earnings at $37.15 EPS and FY2028 earnings at $47.39 EPS.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.77% and a negative return on equity of 207.50%.

A number of other analysts have also commented on the company. StockNews.com raised McKesson from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Mizuho began coverage on shares of McKesson in a research report on Wednesday, December 4th. They set a “neutral” rating and a $630.00 target price on the stock. Baird R W upgraded shares of McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Wells Fargo & Company raised their price target on shares of McKesson from $535.00 to $641.00 and gave the company an “equal weight” rating in a research note on Friday, December 13th. Finally, Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $531.00 to $688.00 in a research note on Thursday, November 7th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, McKesson currently has an average rating of “Buy” and a consensus price target of $645.79.

McKesson Stock Down 0.7 %

NYSE MCK opened at $595.77 on Friday. McKesson has a twelve month low of $464.42 and a twelve month high of $637.51. The business’s fifty day moving average is $589.05 and its 200 day moving average is $562.81. The company has a market cap of $75.63 billion, a price-to-earnings ratio of 30.85, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date is Monday, March 3rd. McKesson’s payout ratio is 13.00%.

Insider Transactions at McKesson

In related news, EVP Leann B. Smith sold 579 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now directly owns 864 shares of the company’s stock, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.11% of the company’s stock.

Institutional Investors Weigh In On McKesson

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Wolff Wiese Magana LLC increased its position in McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after buying an additional 52 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of McKesson during the third quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC acquired a new position in shares of McKesson during the third quarter worth approximately $31,000. Synergy Asset Management LLC bought a new position in shares of McKesson in the 4th quarter worth $32,000. Finally, Crews Bank & Trust bought a new stake in McKesson during the 4th quarter valued at $33,000. 85.07% of the stock is owned by institutional investors.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.